LipoScience Announces Agreement with Scripps Health to Place Vantera Clinical Analyzer within Scripps Health Facilities

LipoScience (NASDAQ: LPDX ) today announced an agreement to place the Vantera® Clinical Analyzer within Scripps Health facilities. The agreement, which marks the first placement of the Vantera Clinical Analyzer in the state of California, will make NMR lipoprotein testing on the analyzer accessible to customers of Scripps Health. The